Omada Health Inc OMDA Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$17.63 down $1.04, 5.57% at close Oct 16
Last close · Previous close $18.67
- Market cap
- At the Oct 16 close
- P/E ratio
- 76.65On last 12 months’ EPS
- Diluted EPS
- $0.23Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$17.63down $1.04, 5.57%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$18.67Oct 15
- Volume808.04KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.49MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $10.28 to $26.92; now $17.63
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
OMDA trailed the S&P 500 in all 4 periods.
| Period | OMDA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OMDA: down 10.8% S&P 500: up 1.5% | OMDA trailed the S&P 500 by 12.3 percentage points Trailed |
| 3M | OMDA: down 25.5% S&P 500: up 1.9% | OMDA trailed the S&P 500 by 27.4 percentage points Trailed |
| YTD | OMDA: up 11.7% S&P 500: up 12.8% | OMDA trailed the S&P 500 by 1.1 percentage points Trailed |
| 1Y | OMDA: down 29.3% S&P 500: up 16.8% | OMDA trailed the S&P 500 by 46.1 percentage points Trailed |
$10,000 invested in OMDA a year ago (Oct 16, 2025) would be worth about $7,069 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,678.
OMDA trailed the S&P 500 in all 4 periods.
| Period | OMDA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OMDA: down 10.8% S&P 500: up 1.2% | OMDA trailed the S&P 500 by 12.0 percentage points Trailed |
| 3M | OMDA: down 25.5% S&P 500: up 1.7% | OMDA trailed the S&P 500 by 27.2 percentage points Trailed |
| YTD | OMDA: up 11.7% S&P 500: up 11.9% | OMDA trailed the S&P 500 by 0.2 percentage points Trailed |
| 1Y | OMDA: down 29.3% S&P 500: up 15.5% | OMDA trailed the S&P 500 by 44.8 percentage points Trailed |
$10,000 invested in OMDA a year ago (Oct 16, 2025) would be worth about $7,069 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $11,553.
All-time high
$26.78
Closing high on . Now 34.2% below that record.
Split-adjusted daily closes since Jun 6, 2025.
Stock splits
OMDA hasn’t split since its price history begins in 2025.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $309.76Mup 47.6%
- Net income
- $4.31M
- Diluted EPS
- $0.23
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $45.52M | −$9.23M | −$1.18 |
| Q4 FY24 (Dec 31, 2024) | $47.98M | −$8.25M | −$1.02 |
| Q1 FY25 (Mar 31, 2025) | $54.96M | −$9.45M | −$1.15 |
| Q2 FY25 (Jun 30, 2025) | $61.37M | −$5.31M | −$0.24 |
| Q3 FY25 (Sep 30, 2025) | $68.03M | −$3.18M | −$0.06 |
| Q4 FY25 (Dec 31, 2025) | $75.85M | $5.16M | $0.26 |
| Q1 FY26 (Mar 31, 2026) | $78.05M | −$2.97M | −$0.05 |
| Q2 FY26 (Jun 30, 2026) | $87.84M | $5.29M | $0.08 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY23 (Dec 31, 2023) | $122.78M | −$67.51M | −$9.52 |
| FY24 (Dec 31, 2024) | $169.80M | −$47.14M | −$6.11 |
| FY25 (Dec 31, 2025) | $260.21M | −$12.78M | −$0.35 |
Margins
- Gross 68.2%
- Operating −0.1%
- Net 1.4%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $17.13MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$23.69MLast 12 months
- Capital spending$6.55MLast 12 months
- 5.5%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $16.84MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
0% of free cash flow
Balance sheet
- $221.71MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$0.00As of Jun 30, 2026
- Net cash$221.71MAs of Jun 30, 2026
- 3.91As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.00As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 1.8%Last 12 months
Over the last 12 months, Omada Health’s net income was 1.8% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 1.4%Last 12 months
Over the last 12 months, Omada Health’s net income was 1.4% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About Omada Health Inc
Omada Health Inc
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
OMDA news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
OMDA stock FAQ
What is OMDA stock’s price today?
Omada Health (OMDA) traded at $17.63 at the close on , down $1.04 (5.57%) from the previous close of $18.67. Over the past 52 weeks it has traded between $10.28 and $26.92.
What is OMDA’s P/E ratio?
OMDA trades at 76.7 times its diluted earnings over the four quarters to ($0.23 per share), at the close. (How the P/E ratio works.)
How much revenue does Omada Health make?
Omada Health reported $309.8 million of revenue over the four quarters to , up 47.6% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $87.8 million, up 43.1% from a year earlier.
Is Omada Health profitable?
Yes. Omada Health earned $4.3 million of net income over the four quarters to , a net margin of 1.4%, and its operating margin was −0.1% (what margins tell you).
What are OMDA’s earnings per share?
OMDA’s diluted earnings per share were $0.23 over the four quarters to , compared with −$3.59 in the twelve months before. The latest quarter (Q2 FY26) brought $0.08 per share, against −$0.24 a year earlier (how EPS works).
Does OMDA pay a dividend?
Omada Health hasn’t paid a dividend in the last twelve months.
What is OMDA’s 52-week high and low?
Over the past 52 weeks OMDA has traded as low as $10.28 and as high as $26.92. At $17.63 at the close on , it is 34.5% below that high and 71.5% above the low.
What is OMDA’s all-time high?
OMDA’s highest closing price was $26.78 on , adjusted for stock splits. At $17.63 at the close on , it is 34.2% below that record.
Has OMDA stock ever split?
No. OMDA hasn’t split since its price history begins in 2025.
How has OMDA stock performed?
Including dividends and measured to the close on , OMDA has returned +11.7% so far this year and −29.3% over the past year. Over the same periods the S&P 500, measured by SPY, returned +12.8% and +16.8%. Past performance doesn’t predict future returns.
What sector and industry is Omada Health in?
Omada Health is in the Healthcare sector and the Health Information Services industry, and is headquartered in California, USA.
What exchange does OMDA trade on?
Omada Health trades on the Nasdaq under the ticker symbol OMDA. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.